Jorgensen, P.L. (1974) Purification and Characterization of (Na+ Plus K+)-ATPase. IV. Estimation of the Purity and of the Molecular Weight and Polypeptide Content Per Enzyme Unit in Preparations from the Outer Medulla of Rabbit Kidney. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 356, 53-67.
http://dx.doi.org/10.1016/0005-2736(74)90293-4

has been cited by the following article:

• TITLE: Kinetic Characterization of Na,K-ATPase Inhibition by the Acetaminophen Metabolite N-Acetylbenzoquinoneimine

  AUTHORS: Jeff B. Helms, Lauren P. Saunders, Jamie Meyer, Charles J. Costa, Eric Plowman, Nick Williford, Matthew Corbitt, Jeremy P. Holden, Craig Gatto

  KEYWORDS: Na, K-ATPase, Paracetamol, N-Acetylbenzoquinoneimine, Overdose, Renal, Electrophillic

  JOURNAL NAME: Open Journal of Molecular and Integrative Physiology, Vol.5 No.1, February 3, 2015

  ABSTRACT: N-acetylbenzoquinoneimine (NABQI) is a toxic metabolite of the common analgesic acetaminophen (APAP). NABQI is an electrophilic intermediate formed via the oxidation of APAP within the cytochrome P450 system. Within the normally recommended low-dose use of APAP, NABQI is a minor metabolite which is either quickly reduced back to APAP or conjugated to Glutathione (GSH) producing an innocuous by-product. However, with overdose or prolonged high-dose usage of acetaminophen, GSH levels can become depleted and the bioactive NABQI is thought to form adducts with proteins and oxidize protein sulfhydryls producing intra- and intermolecular disulfide bridges in proteins. In this work we investigated the effect of NABQI on purified kidney Na,K-ATPase to see if the clinical renal insufficiencies seen in APAP overdose may be linked to inhibition of the Na,K-ATPase. Our work has shown that NABQI does indeed inhibit the Na,K-ATPase in a dose dependent (IC50 = 19.8 ± 2.9 μM) and irreversible manner. Interestingly, brief storage of NABQI at -20°C eliminates the irreversible effects of the compound, and leads to a product that remains a potent reversible inhibitor of the Na,K-ATPase (IC50 = 58.7 ± 19.5 μM). Further, the reversible inhibition produced by stored NABQI competes with para-nitrop.